Trial record 2 of 5 for:    MPACT

A Multi-centre, Prospective Post Marketing Surveillance Study to Assess Mid-term Performance of the Mpact Cup in Subjects Requiring Primary Total Hip Arthroplasty

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Medacta International SA
Information provided by (Responsible Party):
Medacta International SA Identifier:
First received: July 7, 2014
Last updated: July 21, 2014
Last verified: July 2014

This is a multi-centre, prospective post marketing surveillance study to assess mid-term performance of the Mpact cup in subjects requiring primary total hip arthroplasty.

Condition Intervention
Avascular Necrosis
Fracture of the Femoral Neck or Head
Congenital Hip Dysplasia
Device: Mpact Acetabular Shell

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Multi-centre, Prospective Post Marketing Surveillance Study to Assess Mid-term Performance of the Mpact Cup in Subjects Requiring Primary Total Hip Arthroplasty

Resource links provided by NLM:

Further study details as provided by Medacta International SA:

Primary Outcome Measures:
  • The Kaplan-Meier analysis as a measure of implant performance. [ Time Frame: 5 years ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • The Harris Hip Score. [ Time Frame: pre-op, 3/6 months, 1,2 and 5 years ] [ Designated as safety issue: No ]
  • Radiological analysis as a meausure of safety. [ Time Frame: 3/6 months, 1,2 and 5 years ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 200
Estimated Primary Completion Date: June 2020 (Final data collection date for primary outcome measure)

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to the patient's surgery.
  • Those presenting with disease that meets the indications for use for Medacta USA implants defined by this study (on-label use).
  • Patients must be willing to comply with the pre and post-operative evaluation schedule.

Exclusion Criteria:

  • Those with one or more medical conditions identified as a contraindication defined by the labeling on any Medacta implants used in this study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT02196818

Contact: Mara Colombo 0041 91 6966060

United States, Colorado
Vail Orthopedics, P.C. Recruiting
Denver, Colorado, United States, 80230
Contact: Derek Johnson, MD    303-214-4500   
Principal Investigator: Derek Johnson, MD         
United States, Idaho
Saint Alphonsus Regional Medical Center Recruiting
Boise, Idaho, United States, 83702
Contact: Dennis McGee, MD   
Principal Investigator: Dennis McGee, MD         
United States, Illinois
Illinois Bone & Joint Institute, LLC Recruiting
Libertyville, Illinois, United States, 60048
Contact: Peter Thadani, MD    847-247-4000   
Contact: Keri Malcom    847.247.4000   
Principal Investigator: Peter Thadani, MD         
Sub-Investigator: Keri Malcom         
Sponsors and Collaborators
Medacta International SA
  More Information

No publications provided

Responsible Party: Medacta International SA Identifier: NCT02196818     History of Changes
Other Study ID Numbers: P01.014.08/00
Study First Received: July 7, 2014
Last Updated: July 21, 2014
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hip Dislocation, Congenital
Hip Dislocation
Joint Diseases
Musculoskeletal Diseases
Musculoskeletal Abnormalities
Congenital Abnormalities
Wounds and Injuries
Hip Injuries
Pathologic Processes
Bone Diseases
Rheumatic Diseases processed this record on August 28, 2014